Tag: Prescription Drugs
ACP Advises Against Chloroquine, Hydroxychloroquine for COVID-19
Practice points based on lack of evidence supporting use as prophylaxis or treatment for COVID-19
NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19
Trial will enroll 2,000 patients with SARS-COV-2 who have fever, cough, and/or shortness of breath
Atezolizumab-Bevacizumab Beats Sorafenib in Liver Cancer
Overall, progression-free survival longer with combo in unresectable hepatocellular carcinoma
Live Biotherapeutic Promising for Prevention of Bacterial Vaginosis
Following vaginal metronidazole for BV, incidence of recurrence lower with Lactin-V versus placebo
Dexrazoxane Preserves Cardiac Function in Pediatric Leukemia
Beneficial for patients with AML receiving anthracyclines, with no impact on event-free, overall survival
For Those With Heart Failure, ACE2 Concentrations Up in Men
Use of ACE inhibitors, ARBs not tied to higher plasma ACE2 concentrations in those with heart failure
Anakinra May Reduce Systemic Inflammation in COVID-19
At 21 days, survival was 90 percent in anakinra group versus 56 percent in standard treatment group
Triple Antiviral Therapy Promising for Mild-to-Moderate COVID-19
Duration of viral shedding shorter with combination of lopinavir-ritonavir, ribavarin, interferon beta-1b
Hydroxychloroquine Has No Impact on Outcomes in COVID-19
No link seen between use of the drug and risk for composite end point of intubation or death
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
No significant association identified in overlap propensity score weighting analysis
